Member Info for Kong1

Sleepydave.
to follow from my previous post, AS clearly stated that AVACTA may have a therapy as well as the saliva test, Now if AS gave a RNS to say they have achieved both, all the companies youve just mentioned, their share price will plummet., How many will jump ship to ours is anybodys guess, but if we can achieve the unthinkable !!!
i`ll leave it with everyone else to come up with any figures.

Richken
Alot of investers on here are not mentioning the fact, that AS in the statement of 18th june actually said, they could have a potential therapy for covid 19 and here is the text to confirm

Avacta has now successfully completed the initial phase of a collaboration with Professor David Bhella at the University of Glasgow showing that these “neutralising” Affimer reagents prevent a SARS-COV-2 model virus from entering human cells and therefore provide a potential therapy for COVID-19.

so if they can find find a test to tell you if infected and a potential therapy well what more can you say.

And with the cancer trials around the corner, the technology for Affimers is looking seriously beyond believe, what Avacta might have stumbled upon, ( providing tests get the green light ) is breathtaking, and potentially groundbreaking since penicillian was discovered,
Dare I say Nobel peace prize stuff in the making.

And all this technology is patetented so to speak

Mr B, not been in the wetherby whaler for a while, we used to stop off in wetherby after playing up north on a saturday night, stop off in wetherby for last drinks before home, coach full of rugby lads, soon sold out after a hard game

I could sit inbertween you both, be referee, so to speak,

PL75 are you sitting next to Chendog ?

The saliva test has been modified over this last month, for the highest sensitivity AVACTA or CYTIVIA could manage.
if for any reason they wouldnt have been able to do it, we would have had a RNS.
For Avacata to tweet that after hours, was a clear indication that not only have they succeeded in hitting their sensitivity target, but they are letting us know that the US goverment is fast tracking the product as they need something to calm their people down and to tell them help is coming against the battle, this will be met with a huge order to also let the people of the united states know that Trump means business.
Also Avacta now that it has tweeted and told us something very clear, They will have to let the markets know on monday morning as it is possibly a clear indication of market abuse and potential insider trading,
I am convinced Avacta will have to anounce a positive RNS sometime before 8am !

Good luck all, next week is going to be a big roller coaster

Chartmy I feel for you, I’ve been there before, you’re not on your own

My only worry here is that we know the test works, but can they make it sensitive enough to pass the regulations needed

I don’t believe the saliva tests being run at Southampton are anything to do with Avacta.
I also believe this saliva test to be far longer and costlier than what Avactas will be.
If we are talking like AS has previously mentioned ( A pregnancy test with one /two blue lines ) and results in minutes it will simply wipe out all these other tests.
Why would anyone pay more money and wait longer for results when you can have results in minutes and I’m sure Avacta would be cheaper

So a company supply nearly 17% of the test kits in the Uk are not up to standard the Gov said tonight.
The CE Mark is not forthcoming, this is why things take time and have to go through the correct channels.
I will also say that if Avacta get the CE mark approval they will immediately take not only this 17% share but probably most of the rest.
Fingers crossed it’s forthcoming

Extensions, new deals, all very welcome. But we need a trading update to see what revenue is coming in and what is going out !!

Sirius fingers crossed for all 4 ??

cheers sirius, just looked, id not picked up on this, so basically a double edged sword we might have against the virus,
A double revenue source potentially,

Not sure if this has been picked up before, but if it has except my appoligise.
Having just watched the avecta proactive one2one video on you tube, I picked up at aprox 11 mins into the video, AS stating they are working hard and possibly have a potential therapy for the covid 19 !!! they are actively looking for a partner to help them in this area.

Avacta are working at 100 mph to get this saliva test to market make no bones about that. For some of you saying they need to concentrate on this and not to diversify are not understanding how things work.
With all the will in the world finalising the end product is being done at the greatest speed. Certain perimeters will have to be met at certain stages and will obviously take time, whether one person is doing the work or a 100.
Avacta has found another route which opens up a further avenue and one they can work on with current staff without being detrimental to the saliva test.
Once the saliva test is signed off, they will forcus on this water test more and possibly other areas they might think they can exploit.
Patience is needed rome wasn’t built in a day. It will come, it works as they have told us, and this RNS affirms all.

So once the corvid tests are done and sorted, what other diseases or virus’s can the product be targeted at ?
In a few weeks time, once the corvid virus is sorted. What other areas can Avacta target ?

so I take it on your post Jag189 you dont hold any shares in this stock then ?

Jimboo

To win an argument with an intelligent person is very hard,
To win an argument with a stupid one is totally impossible !!

You can pull Avacta to pieces if you want, But the product we are dealing with and the fact that it is for humans, Has to be 100% right in every department, otherwise it will fail at the first hurdle, it is easier to sell a product that gives a 100% result than a 60% one.
Everything has to go through the correct channels.
Do you not think Avacta are wanting this ASAP ? can you imagine the revenue to themselves and how it may affect the company going forward. They want this product and revenue more than you !
All you want is SP to go north ASAP so you can brag how much youve made then move on to the next share, to spout the next lot of unintelligent rubbish.
Understand BUISINESS before you put your brain in gear !!

This is a surprise RNS for sure, But what it does show is what potential Avacta has with its tools.

I would really like to know once corvid is out of the way, what other jobs can be done with these Affirmers and technology that Avacta has.
For me the cancer chemo targeting, is the one, that if works could be mind blowing.
its just down to time and patience.
I also have to say, with all the avenues and deals trying to be finalised, AS must be working at least 20hrs a day.

I’m not a betting man, and I’ve filtered him, but I’m going to stick my neck out to say, global will post to day he sold at 1.22 and bought back in when it bottoms out !